Rendering

Component: (Network and Table)
Network
00300 - Statement - Consolidated Statements Of Cash Flows
(http://www.acadia-pharm.com/role/StatementConsolidatedStatementsOfCashFlows)
Table(Implied)
Slicers (applies to each fact value in each table cell)
Reporting Entity [Axis]0001070494 (http://www.sec.gov/CIK)
Consolidated Statements Of Cash Flows [Abstract]Period [Axis]
2011-01-01 - 2011-12-31
2010-01-01 - 2010-12-31
2009-01-01 - 2009-12-31
Consolidated Statements Of Cash Flows [Abstract]
 
 
 
Cash flows from operating activities
 
 
 
Net income (loss)
(22,765,000) 
15,139,000  
(45,145,000) 
Adjustments to reconcile net income (loss) to net cash used in operating activities:
 
 
 
Depreciation
285,000  
607,000  
1,111,000  
Stock-based compensation
1,598,000  
1,583,000  
2,134,000  
Amortization of investment premium/discount
105,000  
(117,000) 
260,000  
Non-cash charge resulting from lease termination
806,000  
 
 
Other
 
(94,000) 
323,000  
Changes in operating assets and liabilities:
 
 
 
Prepaid expenses, receivables and other current assets
(131,000) 
671,000  
1,013,000  
Other assets
106,000  
26,000  
47,000  
Accounts payable
(29,000) 
(990,000) 
656,000  
Accrued expenses
277,000  
(2,135,000) 
(2,282,000) 
Deferred revenue
(57,000) 
(25,303,000) 
28,178,000  
Other long-term liabilities
(92,000) 
(90,000) 
(22,000) 
Net cash used in operating activities
(19,897,000) 
 
(10,703,000) 
 
(13,727,000) 
 
Cash flows from investing activities
 
 
 
Purchases of investment securities
(48,066,000) 
(54,674,000) 
(50,265,000) 
Maturities of investment securities
54,049,000  
53,486,000  
59,750,000  
Proceeds from sales (purchases) of property and equipment
(3,000) 
128,000  
(41,000) 
Net cash provided by (used in) investing activities
5,980,000  
 
(1,060,000) 
 
9,444,000  
 
Cash flows from financing activities
 
 
 
Proceeds from issuance of common stock and warrants, net of issuance costs
14,022,000  
823,000  
1,923,000  
Repayments of long-term debt
(78,000) 
(353,000) 
(762,000) 
Net cash provided by financing activities
13,944,000  
 
470,000  
 
1,161,000  
 
Effect of exchange rate changes on cash
13,000  
20,000  
73,000  
Net increase (decrease) in cash and cash equivalents
40,000  
 
(11,273,000) 
 
(3,049,000) 
 
Cash and cash equivalents
 
 
 
Beginning of year
6,849,000  
18,122,000  
21,171,000  
End of year
6,889,000  
 
6,849,000  
 
18,122,000  
 
Supplemental schedule of cash flow information
 
 
 
Interest paid
8,000  
37,000  
96,000